排序方式: 共有88条查询结果,搜索用时 9 毫秒
61.
为观察盐酸阿比朵尔对柯萨奇病毒的抑制作用,本实验以利巴韦林为阳性对照药物,采用细胞培养技术、细胞病变效应(CPE)抑制法、活细胞染色计数法(MTT)和培养上清中病毒滴度测定观察盐酸阿比朵尔抗柯萨奇病毒的作用。结果表明盐酸阿比朵尔的半数中毒浓度(TD50)为896.54μg/mL,药物抗病毒生物合成组、药物直接作用组、药物抗病毒吸附2h组、药物抗病毒有吸附8h组的病毒抑制率分别能达到74.48%、45.68%、28.90%和48.27%,在抗生物合成组,盐酸阿比朵尔能明显抑制柯萨奇病毒所致的CPE效应,降低培养上清中的病毒滴度,病毒抑制率随药物浓度增加而增高,存在量效关系。这提示盐酸阿比朵尔在细胞内对柯萨奇病毒有一定的抑制作用。 相似文献
62.
63.
本文旨在建立一种快速、高效的方法检测肠道病毒71型(EV71)和柯萨奇病毒A16型(CA16)的方法,以用于儿童手足口病的病原学监测。通过设计肠道病毒通用引物和CA16与EV71的型特异性引物,建立不同引物浓度配比及两阶段退火温度以提高检测敏感性和特异性的多重反转录聚合酶链反应(RT-PCR)方法,并对首都儿科研究所附属儿童医院2010年3~10月收集的371例手足口病患儿共381份临床标本同时进行病毒分离和核酸检测。结果显示,本研究建立的多重RT-PCR方法对CA16和EV71的最低模板检测浓度分别为5.32 pg/ml和0.64 pg/ml,反应特异度为100%。应用该方法检测381份手足口病临床标本的总阳性率为78.4%,其中CA16与EV71的检测阳性率分别为32.6%和35.8%,二者检测阳性比为1:1.1。以病毒分离为标准,多重RT-PCR对CA16及EV71检测的准确率分别为95.2%和98.6%。因此,本研究新建立的多重RT-PCR方法准确、简便,适用于较大量样本的手足口病病原学监测。2010年引起北京地区儿童手足口病的主要病原为CA16和EV71。 相似文献
64.
65.
Molecular analysis of the role of IRES stem-loop V in replicative capacities and translation efficiencies of Coxsackievirus B3 mutants 总被引:1,自引:0,他引:1
Coxsackievirus B3 (CVB3) is a principal viral cause of acute myocarditis in humans and has been implicated in the pathogenesis
of dilated cardiomyopathy. The natural genetic determinants of cardiovirulence for CVB3 have not been identified, although
using strains engineered in the laboratory, it has been demonstrated elsewhere that, for several wild-type CB3 strains, the
primary molecular determinant of cardiovirulence phenotype localizes to the 5′ nontranslated region (5′NTR) and capsid. Stable
RNA tetraloop motifs are found frequently in biologically active RNAs. These motifs carry out a wide variety of functions
in RNA folding, in RNA–RNA and RNA–protein interactions. A great deal of knowledge about the structures and functions of tetraloop
motifs has accumulated largely due to intensive theoretical, biochemical, and biophysical studies on one most frequently occurring
family of tetraloop sequences, namely, the GNRA sequence, especially the GNAA sequence conserved in all enteroviruses. Here
in this study, through construction of CVB3 chimeric mutants, the predicted stem loop (SL) V within the 5′NTR has been identified
as important in determining viral cardiovirulence. Replication assays in HeLa cell monolayers revealed that wild-type CVB3
virus and two of the six mutants constructed here grow efficiently, whereas other mutant viruses replicate poorly. Furthermore,
the in vitro translation products from these mutants and wild-type CVB3, demonstrated that the two mutants who replicate efficiently,
translated at relatively equivalent amount than the wild-type. However, other mutants demonstrated a low efficiency in their
production of protein when translated in a Rabbit Reticulocytes Lysats. 相似文献
66.
Our previous researches showed that nitronyl nitroxyl derivatives, NNP and NNVP were good anti-oxidants and provided radioprotective effects in C6 cells. The objective of the present study is to investigate the possible antiviral effects and underlying pharmacological of the two nitronyl nitroxide radicals against CVB3 in vitro and in vivo. The results showed that NNP and NNVP were some of the most potent compounds in terms of their antiviral effects by protecting myocardial cells against oxidative damage of free radicals. Treatment with NNP or NNVP could decrease the intracellular ROS level in vitro. They could lead to a significant decrease in activities of biochemical markers AST, CK and LDH in infected murine serum and could increase SOD and CAT activities and decreased MDA activities compared with infected control in vivo. NNP and NNVP could reduce NO production in infected mice by reacting with NO to produce the imino nitroxides which was confirmed by ESR spectrometry. In addition, NNP and NNVP could both decrease the mRNA expression of proinflammatory cytokines, TNF-α, IL-2 and IL-6. In conclusion, nitronyl nitroxide radicals NNP and NNVP were shown to have antiviral activities against CVB3 and they may represent potential therapeutic agents for viral myocarditis. 相似文献
67.
本文旨在分析2011—2016年上海地区手足口病病原谱的构成和主要病原体流行规律,为手足口病的疫情防控和重症预警提供参考。采集2011—2016年哨点医院临床诊断为手足口病的患儿标本,首先进行肠道病毒通用型核酸和分型检测,其次对2012—2016年核酸检测为柯萨奇病毒A组6型(coxsackievirus A6,CA6)阳性样本进行基因型重组检测,分离重组型和非重组型CA6株,比较两者生物学特性。结果显示,2011—2012年秋季上海地区手足口病主要致病原为肠道病毒71型(enterovirus type 71,EV71)和CA16;2012年秋季起CA6成为主要病原体;2013—2014年重组型CA6(recombinant CA6,R CA6)占一定比例;2015—2016年非重组型CA6(non-recombinant CA6,NR CA6)成为优势流行株。R CA6和NR CA6代表株在RD细胞中增殖良好,在KB、MRC-5和HEp-2细胞中未见明显增殖。比较R CA6与NR CA6代表株接种于RD细胞后细胞活性下降的动态变化,未见显著差异。本研究证实,CA6为近年来上海地区手足口病的主要病原体,R CA6和NR CA6的构成比逐年变化,提示持续监测手足口病主要病原体并了解其生物学特性,对上海地区手足口病的防控预警及疫苗研发具有重要意义。 相似文献
68.
69.
通过药物抑制病毒致细胞病变效应实验和药物对病毒空斑形成抑制实验,研究低毒性失配双链核糖核酸(Poly I:C12u)和已知的抗病毒药物双链核糖核酸聚肌胞(Poly I:C)在细胞水平对柯萨奇病毒感染的抑制作用比较,证明Poly I:C12U的抗病毒作用。实验结果表明Poly I:C12U和Poly I:C均可有效地抑制病毒空斑的形成,且量效关系已确定。 相似文献
70.
王一平 《微生物学免疫学进展》2012,40(3):62-66
柯萨奇病毒A组16型(CA16)是引起手足口病(HFMD)的主要病原体,与肠道病毒71型(EV71)交替或共同流行;特别是近年在西太平洋地区呈现流行强度高、重症和死亡人数多的特点,已成为该地区的重大公共卫生问题。研发安全有效的疫苗是控制HFMD流行的有效手段。由于EV71所致疾病在重症和死亡病例中所占比例高,对其疫苗研发得到了广泛关注,全病毒灭活疫苗已进入III期临床,有望即将应用于婴幼儿HFMD的防控。EV71疫苗的顺利研发随之也增加了对CA16疫苗研发的迫切性。近年来日本、新加坡以及中国台湾地区逐渐开始关注CA16相关的研究,我国也有多家企业开展CA16疫苗的研发。本文就CA16的病原学,流行病学,实验室诊断,治疗和预防等方面进行了综述。 相似文献